ARTICLE | Distillery Therapeutics
Neurology
November 13, 2018 6:50 PM UTC
Mouse studies suggest inhibiting BMP6 or promoting NOG expression could help treat cognitive dysfunction in AD. In a mouse model of AD, levels of BMP6 in the hippocampal dentate gyrus were higher than...
BCIQ Company Profiles